Challenges and limitations of anal cancer and precancer screening among people with HIV in a real-world setting
Infection · 2026
DOI: 10.1007/s15010-026-02748-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection, 2026. Verfasst von V Menzel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine IV, LMU University Hospital, LMU Munich, Pettenkoferstr. 8a, 80336, Munich, Germany. Hauptthemen laut MEDLINE: Anus Neoplasms, HIV Infections, Precancerous Conditions, Early Detection of Cancer. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the German Center for Infection Research, the Else-Kröner-Fresenius Stiftung, the Bavarian Gender Equality Grant.
Abstract (Originalsprache)
Purpose
Anal carcinoma (AC) incidence in people with HIV (PWH) is increasing. Guideline-recommended anal-cytology screening facilitates early treatment of precancerous lesions. Data on real-world adherence to screening- and follow-up (F/U)-recommendations remain limited.
Methods
We analyzed routine anal-cytology screening in PWH at a German university hospital-clinic (2017–2023), including frequency of findings, F/U, and final diagnoses.
Results
The study-population included 434 persons with 936 anal-cytology results, representing 25% of person-time of F/U at our clinic. Median age was 55 years, female/male ratio was 5/429, 310 (71%) were MSM. Median CD4-nadir was 242/µl, in 97% viral load was suppressed, 47% were currently smoking. Of 936 swab-results, 882 (94%) were evaluable; 201 (21%) showed abnormalities. Among these, 60 (30%) were ASC-US, 77 (38%) LSIL, 12 (6%) ASC-H, and 52 (26%) HSIL. High-resolution-anoscopy (HRA), recommended for the 64 ASC-H/HSIL-cases, was performed in 7 (11%), identifying 1 AIN2. In 46/64 (72%) proctoscopy identified 1 AC and 3 cases each of AIN2/AIN3. Eleven persons (17%) refused F/U. Thus, 8/64 (12.5%) suspicious cytology findings were histopathologically confirmed. During the study period, 4 cases of AC were diagnosed in unscreened persons at our clinic.
Conclusion
Routine anal-cytology screening in an unsystematically selected cohort of 434 PWH contributing 1,383 person-years of F/U identified 7 cases of high-grade precancerous lesions and 1 asymptomatic AC. Important challenges included low uptake, limited specificity of cytology, inconsistent adherence to F/U recommendations, and insufficient availability of HRA. Improved communication of HIV-care-providers with all involved parties will be a key requirement for improving efficiency and outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine IV, LMU University Hospital, LMU Munich, Pettenkoferstr. 8a, 80336, Munich, Germany.
- Department of Dermatology and Venereology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
- German Centre for Infection Research (DZIF), Partner Site, Munich, Germany.
- Division of Infectious Diseases, Department of Medicine IV, LMU University Hospital, LMU Munich, Pettenkoferstr. 8a, 80336, Munich, Germany. useybold@med.lmu.de.
Förderung
- the German Center for Infection Research
- the Else-Kröner-Fresenius Stiftung
- the Bavarian Gender Equality Grant
- Klinikum der Universität München
Zitieren
APA
Menzel, V., Gruener, E., Neuf, J., Sammet, S., Esser, S., Roider, J., & Seybold, U. (2026). Challenges and limitations of anal cancer and precancer screening among people with HIV in a real-world setting. Infection. https://doi.org/10.1007/s15010-026-02748-4
Vancouver
Menzel V, Gruener E, Neuf J, Sammet S, Esser S, Roider J, et al. Challenges and limitations of anal cancer and precancer screening among people with HIV in a real-world setting. Infection. 2026. doi:10.1007/s15010-026-02748-4
BibTeX
@article{Menzel2026,
author = {Menzel, V and Gruener, E and Neuf, J and Sammet, S and Esser, S and Roider, J and Seybold, U},
title = {Challenges and limitations of anal cancer and precancer screening among people with HIV in a real-world setting},
journal = {Infection},
year = {2026},
doi = {10.1007/s15010-026-02748-4}
}
EUVIMED